Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)
US12115154B2 · kind B2 · utility
0Cited by
37References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2020 |
| Grant date | Oct 15, 2024 |
| Priority date | — |
| Expiry date | Sep 14, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel compounds capable of binding to PCSK9, thereby modulating PCSK9 biological activity. Also provided are compositions comprising these compounds, methods of preparing the compounds, and methods for use of the compounds in the treatment of PCSK9-related conditions and diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.